{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:32:07Z","timestamp":1789810327741,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Programa de Doutorado Sandu\u00edche no Exterior \u2013 CAPES","doi-asserted-by":"publisher","award":["19\/2016"],"award-info":[{"award-number":["19\/2016"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T11:51:14Z","timestamp":1542628274000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Repurposing approach identifies new treatment options for invasive fungal disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Isis Regina Grenier","family":"Capoci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-620X","authenticated-orcid":false,"given":"Daniella Renata","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina Mayumi","family":"Sakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciele Abigail Vilugron","family":"Rodrigues-Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia de Souza","family":"Bonfim-Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Cristina Alexandrino","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rika Seki","family":"Kioshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terezinha Inez Estivalet","family":"Svidzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Maigret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.11.019_b0005","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2018.11.019_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12660","article-title":"ESCMID Study Group for Infections in Compromised Hosts (ESGICH). Invasive fungal infections in solid organ transplant recipients","volume":"20","author":"Gavald\u00e0","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2018.11.019_b0015","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0000000000002698","article-title":"Antifungal prevention of systemic candidiasis in immunocompetent ICU adults: systematic review and meta-analysis of clinical trials","volume":"45","author":"Dupont","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bioorg.2018.11.019_b0020","article-title":"Systemic cryptococcosis in an immune-competent child","author":"Saini","year":"2017","journal-title":"J. Infect.Public Health."},{"key":"10.1016\/j.bioorg.2018.11.019_b0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/0074-02760170310","article-title":"Paracoccidioidomycosis due to Paracoccidioides brasiliensis S1 plus HIV co-infection","volume":"113","author":"Macedo","year":"2018","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bioorg.2018.11.019_b0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","author":"De Pauw","year":"2008","journal-title":"Clin. Infect. Dis. 46"},{"key":"10.1016\/j.bioorg.2018.11.019_b0035","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jac\/dks155","article-title":"European Organization for the Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies","volume":"67","author":"Hoenigl","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2018.11.019_b0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13277-014-2649-7","article-title":"Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0045","first-page":"1","article-title":"Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies","author":"Deng","year":"2017","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bioorg.2018.11.019_b0050","first-page":"1","article-title":"Comparative effectiveness and safety between amphotericin b lipid-formulations: a systematic review","author":"Grazziotin","year":"2018","journal-title":"Int. J. Technol. Assess Health Care"},{"key":"10.1016\/j.bioorg.2018.11.019_b0055","doi-asserted-by":"crossref","DOI":"10.2174\/1568026618666180528121707","article-title":"Emerging virulence, drug resistance and future anti-fungal drugs for Candida pathogens","author":"Srivastava","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2164-12-75","article-title":"Comparative genomics allowed the identification of drug targets against human fungal pathogens","volume":"12","author":"Abadio","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bioorg.2018.11.019_b0065","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s00253-015-7223-8","article-title":"Structural and functional characterization of the recombinant thioredoxin reductase from Candida albicans as a potential target for vaccine and drug design","volume":"100","author":"Godoy","year":"2016","journal-title":"App. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0070","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Arn\u00e9r","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/ars.2000.2.4-811","article-title":"Antioxidant function of thioredoxin and glutaredoxin systems","volume":"2","author":"Holmgren","year":"2000","journal-title":"Antioxid Redox Signal."},{"key":"10.1016\/j.bioorg.2018.11.019_b0080","doi-asserted-by":"crossref","first-page":"27259","DOI":"10.1074\/jbc.M704298200","article-title":"The thioredoxin system of the filamentous fungus Aspergillus nidulans: impact on development and oxidative stress response","volume":"282","author":"Th\u00f6n","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0085","unstructured":"Universidade Estadual de Maring\u00e1, Funda\u00e7\u00e3o Universidade de Bras\u00edlia e Funda\u00e7\u00e3o Universidade do Mato Grosso. Composi\u00e7\u00e3o Farmac\u00eautica baseada em compostos 1,3,4-oxadiaz\u00f3licos e seu uso na prepara\u00e7\u00e3o de medicamentos para tratamento de infec\u00e7\u00f5es sist\u00eamicas. BR 10 2018 009020 8, 3 maio 2018."},{"key":"10.1016\/j.bioorg.2018.11.019_b0090","doi-asserted-by":"crossref","first-page":"e0142926","DOI":"10.1371\/journal.pone.0142926","article-title":"Identification of new antifungal compounds targeting thioredoxin reductase of Paracoccidioides genus","volume":"10","author":"Abadio","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2018.11.019_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2017.12.013","article-title":"Identification of potential inhibitors against nuclear Dam1 complex subunit Ask1 of Candida albicans using virtual screening and MD simulations","author":"Tripathi","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0100","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/ci200192v","article-title":"Identifying compound-target associations by combining bioactivity profile similarity search and public databases mining","volume":"51","author":"Cheng","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2018.11.019_b0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.drudis.2015.12.007","article-title":"In silico methods to address polypharmacology: current status, applications and future perspectives","volume":"21","author":"Lavecchia","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2018.11.019_b0110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1021\/ci200617d","article-title":"Ligand-based virtual screening approach using a new scoring function","volume":"52","author":"Hamza","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2018.11.019_b0115","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry: miniperspective","volume":"57","author":"Maggiora","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/minf.201300054","article-title":"Towards the next generation of computational chemogenomics tools","volume":"32","author":"Rognan","year":"2013","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2018.11.019_b0125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2174\/0929867013372481","article-title":"Phamacophore modeling and three-dimensional database searching for drug design using catalyst","volume":"8","author":"Kurogi","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/157340911793743547","article-title":"Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach","author":"Acharya","year":"2011","journal-title":"Curr.t Comput. Aided Drug Des. 7"},{"key":"10.1016\/j.bioorg.2018.11.019_b0135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2009.06.065","article-title":"Rational drug design","volume":"625","author":"Mandal","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138620711795767866","article-title":"Integrating virtual screening and combinatorial chemistry for accelerated drug discovery","volume":"14","author":"L\u00f3pez-Vallejo","year":"2011","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2018.11.019_b0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.bioorg.2018.11.019_b0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-4598-7-82","article-title":"The prince and the pauper. A tale of anticancer targeted agents","volume":"7","author":"Due\u00f1as-Gonz\u00e1lez","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2018.11.019_b0155","first-page":"1","article-title":"Repositioning drugs and biologics: Retargeting old\/existing drugs for potential new therapeutic applications","volume":"4","author":"Sekhon","year":"2013","journal-title":"J. Pharm. Educ. Res."},{"key":"10.1016\/j.bioorg.2018.11.019_b0160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Van De Waterbeemd","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.11.019_b0165","series-title":"Computer Applications in Pharmaceutical Research and Development","author":"Ekins","year":"2006"},{"key":"10.1016\/j.bioorg.2018.11.019_b0170","doi-asserted-by":"crossref","first-page":"e1004852","DOI":"10.1371\/journal.pcbi.1004852","article-title":"A drug-centric view of drug development: how drugs spread from disease to disease","volume":"12","author":"Rodriguez-Esteban","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","author":"Padhy","year":"2011","journal-title":"J. Postgrad. Med."},{"key":"10.1016\/j.bioorg.2018.11.019_b0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","article-title":"In silico repositioning of approved drugs for rare and neglected diseases","volume":"16","author":"Ekins","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2018.11.019_b0185","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.drudis.2016.06.021","article-title":"Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective","volume":"21","author":"Ferreira","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2018.11.019_b0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.11.019_b0195","doi-asserted-by":"crossref","first-page":"d741","DOI":"10.1136\/bmj.d741","article-title":"Old drugs, new tricks","volume":"342","author":"Shaughnessy","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2018.11.019_b0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2013.03.004","article-title":"Challenges and opportunities of drug repositioning","volume":"34","author":"Novac","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2018.11.019_b0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/adt.2017.29057.pq1","article-title":"Drug repurposing patent applications January\u2013March 2017","volume":"15","author":"Mucke","year":"2017","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13321-017-0213-3","article-title":"Scaffold Hunter: a comprehensive visual analytics framework for drug discovery","volume":"9","author":"Sch\u00e4fer","year":"2017","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2018.11.019_b0215","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","article-title":"The properties of known drugs. 1. Molecular frameworks","volume":"39","author":"Bemis","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/ci600338x","article-title":"The scaffold tree\u2013visualization of the scaffold universe by hierarchical scaffold classification","volume":"47","author":"Schuffenhauer","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2018.11.019_b0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0898-5529(90)90156-3","article-title":"Automatic generation of 3D-atomic coordinates for organic molecules","volume":"3","author":"Gasteiger","year":"1990","journal-title":"Tetrahedron Comput. Methodol."},{"key":"10.1016\/j.bioorg.2018.11.019_b0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.bioorg.2018.11.019_b0240","unstructured":"Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard\u2013Second Edition, CLSI document M27-A3, Clinical and Laboratory Standards Institute, PA, USA, 2008."},{"key":"10.1016\/j.bioorg.2018.11.019_b0245","doi-asserted-by":"crossref","first-page":"170029","DOI":"10.1038\/sdata.2017.29","article-title":"A standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Sci. Data"},{"key":"10.1016\/j.bioorg.2018.11.019_b0250","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.21.5.852","article-title":"Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis","volume":"21","author":"Stevens","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.11.019_b0255","first-page":"180","article-title":"Paracoccidioidomycosis: chronicle of a neglected disease","volume":"78","author":"Canteros","year":"2018","journal-title":"Medicina"},{"key":"10.1016\/j.bioorg.2018.11.019_b0260","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijantimicag.2016.12.020","article-title":"Miltefosine is fungicidal to Paracoccidioides spp. yeast cells but subinhibitory concentrations induce melanisation","volume":"49","author":"Rossi","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2018.11.019_b0265","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","article-title":"Similarity-based virtual screening using 2D fingerprints","volume":"11","author":"Willett","year":"2006","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2018.11.019_b0270","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/minf.201400024","article-title":"The calculation of molecular structural similarity: principles and practice","volume":"33","author":"Willett","year":"2014","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2018.11.019_b0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13321-015-0069-3","article-title":"Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?","volume":"7","author":"Bajusz","year":"2015","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bioorg.2018.11.019_b0280","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/jm401411z","article-title":"Molecular similarity in medicinal chemistry","volume":"57","author":"Maggiora","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0285","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/jm020155c","article-title":"Do structurally similar molecules have similar biological activity?","volume":"45","author":"Martin","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0290","doi-asserted-by":"crossref","first-page":"1600131","DOI":"10.1002\/minf.201600131","article-title":"Modeling tanimoto similarity value distributions and predicting search results","volume":"36","author":"Vogt","year":"2017","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2018.11.019_b0295","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/1381612823666170711112510","article-title":"Virtual screening and statistical analysis in the design of new caffeine analogues molecules with potential epithelial anticancer activity","volume":"24","author":"da Silva Costa","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2018.11.019_b0300","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12859-017-1637-5","article-title":"Drug repositioning for enzyme modulator based on human metabolite-likeness","volume":"18","author":"Lee","year":"2017","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bioorg.2018.11.019_b0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/ci600338x","article-title":"The scaffold tree\u2013visualization of the scaffold universe by hierarchical scaffold classification","volume":"47","author":"Schuffenhauer","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2018.11.019_b0310","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/minf.201300087","article-title":"Visual analysis of biological activity data with Scaffold Hunter","volume":"32","author":"Klein","year":"2013","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bioorg.2018.11.019_b0315","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/ci400100c","article-title":"Scaffold-focused virtual screening: prospective application to the discovery of TTK inhibitors","volume":"53","author":"Langdon","year":"2013","journal-title":"J. Chem. Inf. Mod."},{"key":"10.1016\/j.bioorg.2018.11.019_b0320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13721-018-0166-0","article-title":"A new insight into identification of in silico analysis of natural compounds targeting GPR120","volume":"7","author":"Chinthakunta","year":"2018","journal-title":"Netw. Model. Anal Health Inf. Bioinform."},{"key":"10.1016\/j.bioorg.2018.11.019_b0325","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/jm101020z","article-title":"Quo vadis, virtual screening? A comprehensive survey of prospective applications","volume":"53","author":"Ripphausen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2017.07.030","article-title":"Repurposing antipsychotic drugs into antifungal agents: synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections","volume":"139","author":"Holbrook","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.019_b0335","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","article-title":"Atorvastatin as a promising anticryptococcal agent","author":"de Queiroz Ribeiro","year":"2017","journal-title":"Int. J. Antimicrob. Agents, 49"},{"key":"10.1016\/j.bioorg.2018.11.019_b0340","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01909-17","article-title":"Pharmacodynamics of flubendazole for cryptococcal meningoencephalitis: repurposing and reformulation of an anti-parasitic agent for a neglected fungal disease","author":"Nixon","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.11.019_b0345","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1517\/14656560902911488","article-title":"Treatment of HIV infection with raltegravir","volume":"10","author":"Chirch","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2018.11.019_b0355","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.3390\/molecules170910192","article-title":"Synthetic approaches and pharmacological activity of 1,3,4-oxadiazoles: a review of the literature from 2000\u20132012","volume":"17","author":"de Oliveira","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.11.019_b0350","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2018.11.019_b0360","doi-asserted-by":"crossref","first-page":"318","DOI":"10.24171\/j.phrp.2017.8.5.05","article-title":"Antiviral activity of itraconazole against Echovirus 30 infection in vitro","volume":"8","author":"Lee","year":"2017","journal-title":"Osong Public Health Res. Perspect."},{"key":"10.1016\/j.bioorg.2018.11.019_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2018.05.010","article-title":"Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)","author":"Bauer","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2018.11.019_b0370","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2017.11.011","article-title":"Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae)","volume":"149","author":"Rhoden","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2018.11.019_b0375","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12985-016-0557-8","article-title":"Antiviral activity of micafungin against enterovirus 71","volume":"13","author":"Kim","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.bioorg.2018.11.019_b0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/07357907.2018.1453933","article-title":"Tamoxifen never ceases to amaze: new findings on non-estrogen receptor molecular targets and mediated effects","volume":"36","author":"Bogush","year":"2018","journal-title":"Cancer Invest."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T12:55:52Z","timestamp":1572958552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":76,"alternative-id":["S0045206818309489"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.019","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing approach identifies new treatment options for invasive fungal disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}